SEC Filing Analysis: NutriBand Inc. (NTRB)

Executive Summary

• Trading Significance: High
• Key Takeaway: The Chief Financial Officer reported multiple significant transactions, including a warrant exercise that acquired shares equivalent to 0.50% of the company's total shares outstanding, and two separate option grants representing potential future dilution of 0.77%.
• Market Impact: These transactions are highly significant for a nano-cap company, signaling strong insider alignment and highlighting potential future share dilution that investors should monitor.

Company Information

Field	Value
Company	NutriBand Inc.
Ticker Symbol	NTRB
CIK	0001676047
Industry	Orthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

Field	Value
Name	Goodman Gerald
CIK	0001375666
Title/Position	Chief Financial Officer
Relationship	Officer

Transaction Details

This Form 5 reports multiple transactions. The most significant equity acquisition is detailed below, with other transactions summarized in the analysis.

Field	Value
Form Type	5
Transaction Date	2023-10-27
Transaction Code	X (Exercise of derivative)
Security Type	Common Stock
Shares Involved	60,085
Price Per Share	$1.93
Total Value	$115,964.05
Shares Owned After	66,085
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality (Warrant Exercise)

Metric	Value
Transaction Value	$115,964.05
% of Market Cap	0.13%
Shares Transacted	60,085
% of Shares Outstanding	0.50%
Post-Transaction Ownership	66,085 shares (0.55% of outstanding)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: For NutriBand, with a market cap of only $90 million, insider transactions are closely watched. While the dollar value of the exercise ($116k) is just 0.13% of the market cap (Low), the volume of shares is highly material.
• Ownership Concentration: The exercise establishes a direct common stock ownership of 0.55% for the CFO, a meaningful stake that enhances alignment with shareholder interests.
• Dilution Impact: The filing also reported two option grants: one for 75,000 shares (0.62% of outstanding) and another for 17,667 shares (0.15% of outstanding). Combined, these grants represent potential future dilution of 0.77%, a significant figure for a nano-cap company.
• Transaction Significance: The significance is rated High primarily because the share acquisition from the exercise met the 0.50% of shares outstanding threshold. The additional large option grants further amplify the importance of this filing.

Market Impact Analysis

Stock Impact Prediction

• Direction: Positive/Neutral
• Reasoning: The exercise of warrants is a bullish signal, as the insider is paying to increase their equity stake. However, as this is a late report on a Form 5 and includes grants (which can be seen as dilutive), the immediate market reaction may be muted. The primary signal is long-term insider confidence.

Volume & Sentiment

• Expected Volume Impact: Low to moderate. As this is a Form 5 reporting older transactions, it may not trigger immediate high-volume trading, but it will be incorporated into institutional analysis.
• Sentiment Indicator: Bullish. The combination of exercising derivatives and receiving new grants shows a strong commitment from a key executive.

Investment Insights

Positive Market Indicators

• A key executive (CFO) is increasing their direct ownership in the company.
• The exercise price of $1.93 suggests confidence in the stock's value above that level.
• The grants align the CFO's long-term incentives with share price appreciation.

Risk Factors

• The option grants represent a future potential dilution of 0.77% for existing shareholders.
• The transactions were reported late on a Form 5, not an immediate Form 4, reducing their real-time signaling power.

Key Takeaways

1. High Significance Transaction: The CFO's acquisition of shares via exercise represents 0.50% of all outstanding shares, a material event for a company of this size.
2. Insider Alignment: The combination of the exercise and new option grants demonstrates strong alignment between the CFO and shareholder interests.
3. Potential Dilution: Investors should note the 92,667 shares in new options granted, which could dilute existing shareholders upon exercise in the future.

Additional Context

Transaction Notes

• Summary Filing: This Form 5 is an annual statement of changes in beneficial ownership, summarizing transactions that were not previously reported on a Form 4. The transactions occurred on various dates between October 2023 and January 2025.
• Transaction Breakdown: The filing covers: 1) The exercise of warrants to acquire 60,085 shares of common stock. 2) The corresponding disposition of those warrants. 3) A grant of 75,000 stock options. 4) A grant of 17,667 stock options.